androstenedione has been researched along with Bone Loss, Perimenopausal in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borgfeldt, C; Moberg, L; Nilsson, PM; Samsioe, G | 1 |
Camdeviren, H; Dilek, S; Ertunc, D; Oz, U; Ozdemir, G; Tok, EC | 1 |
Flanagan, AM; Lea, CK; Moxham, V; Reed, MJ | 1 |
Delmas, PD; Pearce, G; Ryan, PF; Seeman, E; Tabensky, DA | 1 |
Arlot, ME; Chapurlat, RD; Claustrat, B; Delmas, PD; Garnero, P; Sornay-Rendu, E | 1 |
Enzelsberger, H; Heytmanek, G; Kurz, C; Metka, M | 1 |
Birkenhäger, JC; De Jong, FH; Valkenburg, HA; van Hemert, AM; Vandenbroucke, JP | 1 |
1 trial(s) available for androstenedione and Bone Loss, Perimenopausal
Article | Year |
---|---|
The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica.
Topics: Aged; Alkaline Phosphatase; Androstenedione; Anti-Inflammatory Agents; Bone and Bones; Bone Density; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Female; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Osteocalcin; Osteoporosis; Osteoporosis, Postmenopausal; Polymyalgia Rheumatica; Prednisolone; Prospective Studies | 1998 |
6 other study(ies) available for androstenedione and Bone Loss, Perimenopausal
Article | Year |
---|---|
Low androstenedione/sex hormone binding globulin ratio increases fracture risk in postmenopausal women. The Women's Health in the Lund Area study.
Topics: Androstenedione; Estradiol; Female; Fractures, Bone; Humans; Incidence; Middle Aged; Osteoporosis, Postmenopausal; Risk Factors; Sex Hormone-Binding Globulin; Women's Health | 2013 |
The effect of circulating androgens on bone mineral density in postmenopausal women.
Topics: Adult; Aged; Androgens; Androstenedione; Bone Density; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Female; Femur Neck; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Radioimmunoassay; Regression Analysis; Testosterone | 2004 |
Androstenedione treatment reduces loss of cancellous bone volume in ovariectomised rats in a dose-responsive manner and the effect is not mediated by oestrogen.
Topics: Androstenedione; Animals; Bone Remodeling; Delayed-Action Preparations; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Osteoporosis, Postmenopausal; Ovariectomy; Rats; Rats, Sprague-Dawley; Testosterone | 1998 |
Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women.
Topics: Absorptiometry, Photon; Adult; Alkaline Phosphatase; Androstenedione; Bone Density; Collagen; Dehydroepiandrosterone; Estradiol; Female; Follicle Stimulating Hormone; Humans; Longitudinal Studies; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Procollagen; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone | 2000 |
[The effects of smoking on estrogen level and bone mass].
Topics: Adult; Androstenedione; Bone Density; Dehydroepiandrosterone; Estradiol; Estrogens; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Smoking | 1989 |
Sex hormone binding globulin in postmenopausal women: a predictor of osteoporosis superior to endogenous oestrogens.
Topics: Androstenedione; Body Height; Body Weight; Bone and Bones; Estradiol; Estrogens; Estrone; Female; Fractures, Bone; Humans; Metacarpus; Middle Aged; Osteoporosis, Postmenopausal; Risk Factors; Sex Hormone-Binding Globulin | 1989 |